Hospitals and private investors keep pumping vast sums of money into an advanced type of radiology whose effectiveness, in many cases, has not yet been shown to justify its price.
More From BioPortfolio on "For Cancer Centers, Proton Therapy’s Promise Is Undercut by Lagging Demand"